VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Short Term Loans and Advances History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Short Term Loans and Advances | ₹65 Cr | ₹62 Cr | ₹50 Cr | ₹58 Cr | ₹45 Cr |
What is the latest Short Term Loans and Advances ratio of VENUS REMEDIES ?
Year | Short Term Loans and Advances |
---|---|
Mar2025 | ₹65 Cr |
Mar2024 | ₹62 Cr |
Mar2023 | ₹50 Cr |
Mar2022 | ₹58 Cr |
Mar2021 | ₹45 Cr |
How is Short Term Loans and Advances of VENUS REMEDIES Trending?
Years | Short Term Loans and Advances | % Change | |
---|---|---|---|
Mar2025 | ₹65 Cr | 5.81 | |
Mar2024 | ₹62 Cr | 24.08 | |
Mar2023 | ₹50 Cr | -14.58 | |
Mar2022 | ₹58 Cr | 30.09 | |
Mar2021 | ₹45 Cr | - |
Compare Short Term Loans and Advances of peers of VENUS REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VENUS REMEDIES | ₹605.5 Cr | -2.4% | -0.3% | 36.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹400,329.0 Cr | 0.9% | 3.7% | -13.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹173,991.0 Cr | 7.4% | 9% | 8.2% | Stock Analytics | |
CIPLA | ₹126,326.0 Cr | 3.3% | 0.2% | -7.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,126.0 Cr | -0.7% | -1.7% | -0.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,324.0 Cr | 1% | -3.2% | -5.2% | Stock Analytics |
VENUS REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VENUS REMEDIES | -2.4% |
-0.3% |
36.1% |
SENSEX | 0.7% |
1.1% |
0.9% |
You may also like the below Video Courses